Why is Lactose (India) falling/rising?
2025-12-03 00:27:34Recent Price Movement and Market Context Lactose (India) has been on a downward trajectory over the past week, losing 6.77% compared to a modest 0.65% gain in the Sensex during the same period. This contrasts sharply with the broader market's resilience, highlighting the stock's relative weakness. Over the last month, however, the stock managed a slight positive return of 1.64%, marginally outperforming the Sensex's 1.43% gain. Despite this short-term uptick, the year-to-date performance remains deeply negative, with the stock down 45.44%, while the Sensex has advanced by 8.96%. Over the last year, the divergence is even starker, with Lactose (India) falling 47.45% against a 6.09% rise in the benchmark index. This extended underperformance suggests that investors have ...
Read MoreWhy is Lactose (India) falling/rising?
2025-11-17 21:26:38As of 17-Nov, Lactose (India) Ltd is experiencing a price increase, currently at Rs 126.40, reflecting a rise of Rs 11.4 or 9.91%. The stock has shown strong performance today, outperforming its sector by 9.63% and has gained consecutively over the last three days, accumulating a total return of 18.02% during this period. It opened with a significant gain of 3.43% and reached an intraday high of Rs 126.5, which is a 10% increase. Additionally, Lactose (India) is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The recent increase in investor participation, with a 63.43% rise in delivery volume compared to the 5-day average, further supports the stock's upward movement. There is no information available regarding positive or negative factors that could influence the stock. Broader market context shows that Lactose (India) has significantly outperfor...
Read More
Lactose (India) Ltd Gains 10% Today, Surpassing Sensex Amid Strong Buying Activity and Milestones
2025-11-17 14:00:20Lactose (India) Ltd is experiencing notable buying activity, with a significant stock increase today and a strong performance over the past week. The stock has shown resilience despite earlier challenges, reflecting a positive trend in the pharmaceuticals and biotechnology sector, supported by robust buyer sentiment.
Read MoreWhy is Lactose (India) falling/rising?
2025-11-14 21:38:25As of 14-Nov, Lactose (India) Ltd is experiencing a price increase, currently at 115.00, which reflects a rise of 7.1 or 6.58%. The stock has shown positive momentum, gaining 7.28% over the last two days, despite opening with a loss of 2.55% today. It reached an intraday high of Rs 118, indicating strong upward movement during the trading session. However, the stock has been volatile, with an intraday volatility of 7.24%, and it has traded in a wide range of Rs 15.95. In terms of performance against benchmarks, the stock has outperformed its sector by 6.12%, but its year-to-date return remains significantly negative at -46.73%. Additionally, there has been a decline in investor participation, with delivery volume falling by 36.13% against the 5-day average, which may impact future price movements. Broader Market Context: In the short term, Lactose (India) Ltd has outperformed the Sensex, which has only inc...
Read More
Lactose (India) Reports Strong Financial Metrics Amidst Cash Flow Challenges
2025-11-14 11:01:19Lactose (India) reported strong financial metrics for the quarter ending September 2025, with record net sales of Rs 41.18 crore and a robust operating profit to interest ratio. However, challenges persist, including negative operating cash flow and a significant decline in profit after tax over the nine-month period.
Read More
Lactose (India) Q2 FY26: Strong Revenue Growth Masks Margin Erosion Concerns
2025-11-14 09:26:23Lactose (India) Ltd., a Gujarat-based pharmaceutical and dairy products manufacturer, reported net profit of ₹2.16 crores for Q2 FY26, marking a 44.00% sequential increase from ₹1.50 crores in Q1 FY26 and a 6.40% rise from ₹2.03 crores in Q2 FY25. Despite the profit growth, the company's shares have struggled significantly, plunging 36.14% over the past year and trading at ₹107.70 as of November 14, 2025, reflecting investor concerns about operational efficiency and margin sustainability.
Read MoreHow has been the historical performance of Lactose (India)?
2025-11-13 23:12:54Answer: The historical performance of Lactose (India) shows a significant growth trajectory in net sales and profitability over the years, with net sales increasing from INR 34.96 crore in March 2021 to INR 116.40 crore in March 2025. The total operating income has mirrored this growth, reaching INR 116.40 crore in March 2025, up from INR 34.96 crore in March 2021. The operating profit (PBDIT) has also seen fluctuations, peaking at INR 20.13 crore in March 2024 before slightly declining to INR 18.41 crore in March 2025. Profit before tax has improved from a loss of INR 3.27 crore in March 2021 to a profit of INR 6.92 crore in March 2025, while profit after tax followed a similar trend, rising from a loss of INR 2.48 crore in March 2021 to INR 5.16 crore in March 2025. In terms of expenses, raw material costs have increased significantly, reaching INR 60.51 crore in March 2025, which reflects the rising op...
Read More
Lactose (India) Faces Evaluation Shift Amidst Declining Performance and High Debt Concerns
2025-11-13 08:03:09Lactose (India), a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment reflecting ongoing challenges. The company's performance indicators present a mixed outlook, with concerns over its high Debt to EBITDA ratio and significant profit decline, contributing to its underperformance against broader market indices.
Read MoreHow has been the historical performance of Lactose (India)?
2025-11-13 00:04:48Answer: The historical performance of Lactose (India) shows a significant growth trend in net sales and profitability over the years, with net sales increasing from 34.96 Cr in Mar'21 to 116.40 Cr in Mar'25. The total operating income followed a similar trajectory, rising from 40.61 Cr in Mar'19 to 116.40 Cr in Mar'25. The company's operating profit (PBDIT) also demonstrated growth, reaching 18.41 Cr in Mar'25, although it peaked at 20.13 Cr in Mar'24. Profit before tax saw fluctuations, with a notable increase to 6.92 Cr in Mar'25 from a loss of 3.27 Cr in Mar'21. Profit after tax also improved, reaching 5.16 Cr in Mar'25, compared to a loss of 2.48 Cr in Mar'21. The earnings per share (EPS) rose to 4.1 in Mar'25 from a negative EPS in Mar'21. On the balance sheet, total assets increased from 84.00 Cr in Mar'20 to 133.47 Cr in Mar'25, while total liabilities also grew, reflecting a rise from 36.03 Cr in Ma...
Read MoreIntimation For Adoption Of New Line(S) Of Business And Product Development / Product Launch Information
30-Jan-2026 | Source : BSEPursuant to the provisions of Regulation 30 of SEBI (LODR) Regulations 2015 we hereby submit the intimation towards the adoption of New Line(s) of Business and Product Development / Product Launch Information.
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
16-Jan-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(4)(f) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SST Private Family Trust
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
16-Jan-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(4)(f) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available